Andrew Fariello, ’95, to keynote ceremony welcoming the Class of 2029

The MUSC College of Pharmacy’s 2025 White Coat Ceremony, held August 15, 2025, in Room 110 of the Drug Discovery Building on the MUSC campus, will feature keynote speaker Andrew Fariello, ’95.

Fariello just celebrated his 30^th reunion, having earned his Pharm.D. from the MUSC College of Pharmacy in 1995. Currently he is vice president of global medical affairs, head medical excellence for AstraZeneca. He joined MUSC from St. John’s University, where he earned a BS in pharmacy in 1989 and then an MS in pharmacy in 1992. While a student, he worked at St. John’s Queen’s Hospital and then, from 1991-1993, as an oncology pharmacist at Long Island Jewish Medical Center in New York.

After graduation, he completed a specialty residency in pediatrics at All Children’s Hospital in St. Petersburg, Florida, and went on to serve as a clinical pharmacist there for five years, where among other duties he developed the clinical pharmacy service for pediatric intensive care and administered clinical trial programs.

In 2000, he joined AstraZeneca Pharmaceuticals as a respiratory medical science liaison covering the Southeastern US. He has served in roles of increasing responsibility ever since, including leading the US Cardiovascular Medical Affairs team, chief of staff for USMA, where he led HQ and field medical affairs teams for multiple disease states and was responsible for the development and execution of medical affairs brand strategy. In 2018, he joined the Global Oncology organization as head of global medical capabilities, and most recently as the vice president and head of medical excellence, overseeing the strategy and delivery of medical affairs teams across the globe. 

 

He is sponsor for AstraZeneca’s post-Pharm.D. Fellowship Program, which has grown to include more than 20 fellows per year in fields including Medical Affairs, Regulatory, R&D, to Commercial. He is a strong advocate for the role of pharmacists in the Pharmaceutical & Biotechnology industries.